APO RESEARCH · REPORT
Hemodialysis Concentrates
Hemodialysis concentrates including:
Product & engineering
Understand the product.
Hemodialysis concentrates including:
Acid concentrates
A-concentrate
Acidified concentrated mixture of salts that, when diluted with dialysis water and bicarbonate concentrate, yields dialysis fluid for use in dialysis
Note 1 to entry: The term “acid” refers to the small amount of acid (for example, acetic acid or citric acid) that is included in the concentrate.
Note 2 to entry: Acid concentrate may contain glucose.
Note 3 to entry: Acid concentrate may be in the form of a liquid, a dry powder, other highly concentrated media, or some combination of these forms.
Bicarbonate concentrates
B-concentrate
Concentrated preparation of sodium bicarbonate that, when diluted with dialysis water and acid concentrate, makes dialysis fluid used for dialysis
Note 1 to entry: Sodium bicarbonate is also known as sodium hydrogen carbonate.
Note 2 to entry: Some bicarbonate concentrates also contain sodium chloride.
Note 3 to entry: Bicarbonate concentrate may be in the form of a liquid or a dry powder.
Note 4 to entry: Dry sodium bicarbonate, without added sodium chloride, is also used in concentrate generators to produce a concentrated solution of sodium bicarbonate used by the dialysis machine to make dialysis fluid.
Selected research
Market Structure
Global Hemodialysis Concentrates Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Hemodialysis concentrates including:
Acid concentrates
A-concentrate
Read the full market overview
Acidified concentrated mixture of salts that, when diluted with dialysis water and bicarbonate concentrate, yields dialysis fluid for use in dialysis
Note 1 to entry: The term “acid” refers to the small amount of acid (for example, acetic acid or citric acid) that is included in the concentrate.
Note 2 to entry: Acid concentrate may contain glucose.
Note 3 to entry: Acid concentrate may be in the form of a liquid, a dry powder, other highly concentrated media, or some combination of these forms.
Bicarbonate concentrates
B-concentrate
Concentrated preparation of sodium bicarbonate that, when diluted with dialysis water and acid concentrate, makes dialysis fluid used for dialysis
Note 1 to entry: Sodium bicarbonate is also known as sodium hydrogen carbonate.
Note 2 to entry: Some bicarbonate concentrates also contain sodium chloride.
Note 3 to entry: Bicarbonate concentrate may be in the form of a liquid or a dry powder.
Note 4 to entry: Dry sodium bicarbonate, without added sodium chloride, is also used in concentrate generators to produce a concentrated solution of sodium bicarbonate used by the dialysis machine to make dialysis fluid.
Global Hemodialysis Concentrates key players include Fresenius Medical Care, Baxter, B. Braun, etc. Global top three manufacturers hold a share about 60%.
North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific, both have a share about 50 percent.
In terms of product, Acid Concentrates is the largest segment, with a share about 65%. And in terms of application, the largest application is Dialysis Center, followed by Home.
This report provides an overview of the global Hemodialysis Concentrates market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Hemodialysis Concentrates and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Hemodialysis Concentrates sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hemodialysis Concentrates market size, projected growth trends, production technologies, key applications, and end-use industries.
Hemodialysis Concentrates Segment by Company
Fresenius Medical Care
Baxter
B. Braun
Rockwell Medical
Nipro
MEDIVATORS
Dialysis Medical Solutions
Unipharm JSC
Nikkiso
Renacon Pharma
Surni Group
Weigao Group
BIOLIGHT
Ziweishan
United Jieran
Sichuang
Sanxin
Shenyouda
Evertrust
Taishikang
Hemodialysis Concentrates Segment by Type
Acid Concentrates
Bicarbonate Concentrates
Hemodialysis Concentrates Segment by Application
Dialysis Center
Home
Hemodialysis Concentrates Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemodialysis Concentrates market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hemodialysis Concentrates and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemodialysis Concentrates.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Hemodialysis Concentrates market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemodialysis Concentrates manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hemodialysis Concentrates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Hemodialysis Concentrates in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Acid Concentrates
- Bicarbonate Concentrates
Applications
- Dialysis Center
- Home
Companies covered
- Fresenius Medical Care
- Baxter
- B. Braun
- Rockwell Medical
- Nipro
- MEDIVATORS
- Dialysis Medical Solutions
- Unipharm JSC
- Nikkiso
- Renacon Pharma
- Surni Group
- Weigao Group
- BIOLIGHT
- Ziweishan
- United Jieran
- Sichuang
- Sanxin
- Shenyouda
- Evertrust
- Taishikang
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Hemodialysis Concentrates Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Hemodialysis Concentrates Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Hemodialysis Concentrates Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Hemodialysis Concentrates Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Hemodialysis Concentrates Market Dynamics
- 2.1 Hemodialysis Concentrates Industry Trends
- 2.2 Hemodialysis Concentrates Industry Drivers
- 2.3 Hemodialysis Concentrates Industry Opportunities and Challenges
- 2.4 Hemodialysis Concentrates Industry Restraints
3 Hemodialysis Concentrates Market by Manufacturers
- 3.1 Global Hemodialysis Concentrates Revenue by Manufacturers (2021-2026)
- 3.2 Global Hemodialysis Concentrates Sales by Manufacturers (2021-2026)
- 3.3 Global Hemodialysis Concentrates Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Hemodialysis Concentrates Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Hemodialysis Concentrates Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Hemodialysis Concentrates Manufacturers, Product Type & Application
- 3.7 Global Hemodialysis Concentrates Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Hemodialysis Concentrates Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Hemodialysis Concentrates Players Market Share by Revenue in 2025
- 3.8.3 2025 Hemodialysis Concentrates Tier 1, Tier 2, and Tier 3
4 Hemodialysis Concentrates Market by Type
- 4.1 Hemodialysis Concentrates Type Introduction
- 4.1.1 Acid Concentrates
- 4.1.2 Bicarbonate Concentrates
- 4.2 Global Hemodialysis Concentrates Sales by Type
- 4.2.1 Global Hemodialysis Concentrates Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Hemodialysis Concentrates Sales by Type (2021-2032)
- 4.2.3 Global Hemodialysis Concentrates Sales Market Share by Type (2021-2032)
- 4.3 Global Hemodialysis Concentrates Revenue by Type
- 4.3.1 Global Hemodialysis Concentrates Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Hemodialysis Concentrates Revenue by Type (2021-2032)
- 4.3.3 Global Hemodialysis Concentrates Revenue Market Share by Type (2021-2032)
5 Hemodialysis Concentrates Market by Application
- 5.1 Hemodialysis Concentrates Application Introduction
- 5.1.1 Dialysis Center
- 5.1.2 Home
- 5.2 Global Hemodialysis Concentrates Sales by Application
- 5.2.1 Global Hemodialysis Concentrates Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Hemodialysis Concentrates Sales by Application (2021-2032)
- 5.2.3 Global Hemodialysis Concentrates Sales Market Share by Application (2021-2032)
- 5.3 Global Hemodialysis Concentrates Revenue by Application
- 5.3.1 Global Hemodialysis Concentrates Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Hemodialysis Concentrates Revenue by Application (2021-2032)
- 5.3.3 Global Hemodialysis Concentrates Revenue Market Share by Application (2021-2032)
6 Global Hemodialysis Concentrates Sales by Region
- 6.1 Global Hemodialysis Concentrates Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Hemodialysis Concentrates Sales by Region (2021-2032)
- 6.2.1 Global Hemodialysis Concentrates Sales by Region (2021-2026)
- 6.2.2 Global Hemodialysis Concentrates Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Hemodialysis Concentrates Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Hemodialysis Concentrates Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Hemodialysis Concentrates Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Hemodialysis Concentrates Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Hemodialysis Concentrates Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Hemodialysis Concentrates Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Hemodialysis Concentrates Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Hemodialysis Concentrates Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Hemodialysis Concentrates Revenue by Region
- 7.1 Global Hemodialysis Concentrates Revenue by Region
- 7.1.1 Global Hemodialysis Concentrates Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Hemodialysis Concentrates Revenue by Region (2021-2026)
- 7.1.3 Global Hemodialysis Concentrates Revenue by Region (2027-2032)
- 7.1.4 Global Hemodialysis Concentrates Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Hemodialysis Concentrates Revenue (2021-2032)
- 7.2.2 North America Hemodialysis Concentrates Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Hemodialysis Concentrates Revenue (2021-2032)
- 7.3.2 Europe Hemodialysis Concentrates Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Hemodialysis Concentrates Revenue (2021-2032)
- 7.4.2 Asia-Pacific Hemodialysis Concentrates Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Hemodialysis Concentrates Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Hemodialysis Concentrates Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Fresenius Medical Care
- 8.1.1 Fresenius Medical Care Company Information
- 8.1.2 Fresenius Medical Care Business Overview
- 8.1.3 Fresenius Medical Care Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Fresenius Medical Care Hemodialysis Concentrates Product Portfolio
- 8.1.5 Fresenius Medical Care Recent Developments
- 8.2 Baxter
- 8.2.1 Baxter Company Information
- 8.2.2 Baxter Business Overview
- 8.2.3 Baxter Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Baxter Hemodialysis Concentrates Product Portfolio
- 8.2.5 Baxter Recent Developments
- 8.3 B. Braun
- 8.3.1 B. Braun Company Information
- 8.3.2 B. Braun Business Overview
- 8.3.3 B. Braun Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 B. Braun Hemodialysis Concentrates Product Portfolio
- 8.3.5 B. Braun Recent Developments
- 8.4 Rockwell Medical
- 8.4.1 Rockwell Medical Company Information
- 8.4.2 Rockwell Medical Business Overview
- 8.4.3 Rockwell Medical Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Rockwell Medical Hemodialysis Concentrates Product Portfolio
- 8.4.5 Rockwell Medical Recent Developments
- 8.5 Nipro
- 8.5.1 Nipro Company Information
- 8.5.2 Nipro Business Overview
- 8.5.3 Nipro Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Nipro Hemodialysis Concentrates Product Portfolio
- 8.5.5 Nipro Recent Developments
- 8.6 MEDIVATORS
- 8.6.1 MEDIVATORS Company Information
- 8.6.2 MEDIVATORS Business Overview
- 8.6.3 MEDIVATORS Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 MEDIVATORS Hemodialysis Concentrates Product Portfolio
- 8.6.5 MEDIVATORS Recent Developments
- 8.7 Dialysis Medical Solutions
- 8.7.1 Dialysis Medical Solutions Company Information
- 8.7.2 Dialysis Medical Solutions Business Overview
- 8.7.3 Dialysis Medical Solutions Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Dialysis Medical Solutions Hemodialysis Concentrates Product Portfolio
- 8.7.5 Dialysis Medical Solutions Recent Developments
- 8.8 Unipharm JSC
- 8.8.1 Unipharm JSC Company Information
- 8.8.2 Unipharm JSC Business Overview
- 8.8.3 Unipharm JSC Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Unipharm JSC Hemodialysis Concentrates Product Portfolio
- 8.8.5 Unipharm JSC Recent Developments
- 8.9 Nikkiso
- 8.9.1 Nikkiso Company Information
- 8.9.2 Nikkiso Business Overview
- 8.9.3 Nikkiso Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Nikkiso Hemodialysis Concentrates Product Portfolio
- 8.9.5 Nikkiso Recent Developments
- 8.10 Renacon Pharma
- 8.10.1 Renacon Pharma Company Information
- 8.10.2 Renacon Pharma Business Overview
- 8.10.3 Renacon Pharma Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Renacon Pharma Hemodialysis Concentrates Product Portfolio
- 8.10.5 Renacon Pharma Recent Developments
- 8.11 Surni Group
- 8.11.1 Surni Group Company Information
- 8.11.2 Surni Group Business Overview
- 8.11.3 Surni Group Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Surni Group Hemodialysis Concentrates Product Portfolio
- 8.11.5 Surni Group Recent Developments
- 8.12 Weigao Group
- 8.12.1 Weigao Group Company Information
- 8.12.2 Weigao Group Business Overview
- 8.12.3 Weigao Group Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Weigao Group Hemodialysis Concentrates Product Portfolio
- 8.12.5 Weigao Group Recent Developments
- 8.13 BIOLIGHT
- 8.13.1 BIOLIGHT Company Information
- 8.13.2 BIOLIGHT Business Overview
- 8.13.3 BIOLIGHT Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 BIOLIGHT Hemodialysis Concentrates Product Portfolio
- 8.13.5 BIOLIGHT Recent Developments
- 8.14 Ziweishan
- 8.14.1 Ziweishan Company Information
- 8.14.2 Ziweishan Business Overview
- 8.14.3 Ziweishan Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Ziweishan Hemodialysis Concentrates Product Portfolio
- 8.14.5 Ziweishan Recent Developments
- 8.15 United Jieran
- 8.15.1 United Jieran Company Information
- 8.15.2 United Jieran Business Overview
- 8.15.3 United Jieran Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 United Jieran Hemodialysis Concentrates Product Portfolio
- 8.15.5 United Jieran Recent Developments
- 8.16 Sichuang
- 8.16.1 Sichuang Company Information
- 8.16.2 Sichuang Business Overview
- 8.16.3 Sichuang Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Sichuang Hemodialysis Concentrates Product Portfolio
- 8.16.5 Sichuang Recent Developments
- 8.17 Sanxin
- 8.17.1 Sanxin Company Information
- 8.17.2 Sanxin Business Overview
- 8.17.3 Sanxin Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Sanxin Hemodialysis Concentrates Product Portfolio
- 8.17.5 Sanxin Recent Developments
- 8.18 Shenyouda
- 8.18.1 Shenyouda Company Information
- 8.18.2 Shenyouda Business Overview
- 8.18.3 Shenyouda Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.18.4 Shenyouda Hemodialysis Concentrates Product Portfolio
- 8.18.5 Shenyouda Recent Developments
- 8.19 Evertrust
- 8.19.1 Evertrust Company Information
- 8.19.2 Evertrust Business Overview
- 8.19.3 Evertrust Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.19.4 Evertrust Hemodialysis Concentrates Product Portfolio
- 8.19.5 Evertrust Recent Developments
- 8.20 Taishikang
- 8.20.1 Taishikang Company Information
- 8.20.2 Taishikang Business Overview
- 8.20.3 Taishikang Hemodialysis Concentrates Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.20.4 Taishikang Hemodialysis Concentrates Product Portfolio
- 8.20.5 Taishikang Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Hemodialysis Concentrates Value Chain Analysis
- 9.1.1 Hemodialysis Concentrates Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Hemodialysis Concentrates Production Mode & Process
- 9.2 Hemodialysis Concentrates Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Hemodialysis Concentrates Distributors
- 9.2.3 Hemodialysis Concentrates Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst